FRANKLIN, Tenn.--(BUSINESS WIRE)--Community Health Systems, Inc. (NYSE: CYH) (the “Company”) announced today that, on February 2, 2026, its wholly owned subsidiary, CHS/Community Health Systems, Inc., ...

Nick is a freelance writer from Chicago, IL, with a BA in Creative Writing from the University of Illinois at Urbana-Champaign. His lifelong belief in the artistic power of video games led him to ...

DALLAS, TX / ACCESS Newswire / January 15, 2026 / Tectonic Financial, Inc. ("Tectonic Financial" or the "Company") (Nasdaq:TECTP), a diversified banking and financial services holding company, today ...

Instil Bio, Inc. (NASDAQ: TIL) stock is trading lower on Tuesday. Axion Bio Inc., a wholly-owned subsidiary of Instil, decided to discontinue clinical development of AXN-2510. AXN-2510, Instil’s lead ...

Adicet Bio ( (ACET)) just unveiled an announcement. On December 19, 2025, Adicet Bio, Inc. held a Special Meeting of Stockholders at which investors approved an amendment to the company’s Restated ...

One of the biggest open-world games is now available on your phone, and if you have Netflix, you don't need to pay extra for it. Oscar Gonzalez is a Texas native who covered video games, conspiracy ...

KALA BIO, Inc. (NASDAQ: KALA) shares jumped 22.16% to $1.13 in after-hours trading on Wednesday. Check out the current price of KALA stock here. Securities and Exchange Commission filings indicate ...

GameSpot may get a commission from retail offers. Rockstar Games launched the new version of Red Dead Redemption on modern consoles and mobile today, December 2, but the rollout did not go entirely ...

Targeting up to 100x improvement in efficiency to enable 10x more affordable IVIg Lyric Bio, Inc., (Lyric) a next-generation biomanufacturing startup developing human-tissue-based production systems ...

Jeff Bezos has had quite a hectic week, having just concluded his third venture capital investment in a promising artificial intelligence startup. This time, the recipient of Bezos’s largesse is a ...

Shares of Korro Bio Inc. lost two-thirds of their value in the extended session Wednesday after the biotech company said it was pausing its work with Novo Nordisk, the weight loss-medication ...

ABL Bio Inc. inked a license and research agreement with Eli Lilly and Co. worth up to $2.6 billion to develop multiple therapeutics using the Grabody-B platform. Under the terms announced Nov. 12, ...